🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this prospective, single-institution observational study is ...
Status
Completed
Location
UNC Hospital
Start Date
2019-06-20
Trial ID
NCT03885830
This pilot clinical trial studies the feasibility of choosing treatment bas...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2015-09-11
Trial ID
NCT02551718
Background: Advanced urothelial cancer has no cure. But only a few chemoth...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2017-03-27
Trial ID
NCT02788201
Treatments Being Tested
The aim of this study was to evaluate the real-world treatment patterns, he...
Status
Completed
Location
Novartis
Start Date
2024-02-27
Trial ID
NCT07188428
Evaluation of the efficacy and safety of withdrawal of tyrosine kinase inhi...
Status
Active Not Recruiting
Location
University Hospital Brno
Start Date
2020-06-16
Trial ID
NCT04147533
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of ruxolitinib...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2013-07-24
Trial ID
NCT01751425
Treatments Being Tested
The purpose of this Australian study was to assess the efficacy and safety ...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2014-07-07
Trial ID
NCT02108951
Treatments Being Tested
The purpose of this study is to determine if adding Ruxolitinib to a Tyrone...
Status
Active Not Recruiting
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2019-11-19
Trial ID
NCT03610971
Treatments Being Tested
This was a retrospective, non-interventional, observational cohort study us...
Status
Completed
Location
Novartis
Start Date
2023-05-23
Trial ID
NCT06692803
This CML disease registry (ASC4REAL-2) aims to gather evidence on the toler...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2025-12-17
Trial ID
NCT07091019
Treatments Being Tested